Richard A. Larson to Secondary Prevention
This is a "connection" page, showing publications Richard A. Larson has written about Secondary Prevention.
Connection Strength
0.023
-
Individual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemia. Blood. 2011 Jun 30; 117(26):7007-13.
Score: 0.023